TELA 8-K 2026-11-10

TELA Bio, Inc. (TELA) 8-K dated 2026-11-10 — accession 0001104659-26-125147.

TELA Bio, Inc. (TELA) is a medical devices company listed on NASDAQ.

TELA: TELA Bio Reports

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported TELA revenue for 2025-12-31 was $80.3M. Net income was -$38.8M. Revenue was up 15.8% from 2024-12-31 to 2025-12-31. TELA currently screens at market cap $38.5M.

Not investment advice. The TELA SEC hub lists recent forms. The stock page is the research view.